In routine clinical practice, p16 immunohistology followed by HPV DNA detection (PCR or in situ hybridization) has proven effective in identifying oropharyngeal carcinomas that are truly HPV-associated. This evidence concerns the gene CDKN2A and oropharyngeal carcinoma.